Makes me cringe too. There a bit of sensationalism going on and it's unfortunate because we're a public company with retail investors. Some will be quick to claim the company misled them if trials fail.
The conflicting info on dosing and disease progression, the occasional misleading use and portrayal of data... We can do better. BP is smarter enough though, they don't get fooled easily. If we eventually get a partnership offer, it's all moot.
News 
Market Data 
Discover 
